Intervention Review

You have free access to this content

Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma

  1. T S Shylasree1,*,
  2. Andrew Bryant2,
  3. Ram Athavale3

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 28 FEB 2013

Assessed as up-to-date: 28 JAN 2013

DOI: 10.1002/14651858.CD006246.pub2


How to Cite

Shylasree TS, Bryant A, Athavale R. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma . Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD006246. DOI: 10.1002/14651858.CD006246.pub2.

Author Information

  1. 1

    Tata Memorial Centre, Gynaecological Oncology Division, Department of Surgical Oncology, Mumbai, India

  2. 2

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

  3. 3

    University Hospital Coventry and Warwickshire NHS Trust, Gynaecological Oncology, Coventry, UK

*T S Shylasree, Gynaecological Oncology Division, Department of Surgical Oncology, Tata Memorial Centre, Dr Ernest Borges Marg, Parel, Mumbai, 400012, India. shyla_sree@hotmail.com. shylasree@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 28 FEB 2013

SEARCH

References

Additional references

Andersen 1989
Ariyoshi 2000
Barnholtz-Sloan 2004
  • Barnholtz-Sloan JS, Morris R, Malone JM, Jr, Munkarah AR. Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT). Gynecologic Oncology 2004;93(2):506-12.
Benedet 2000
  • Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorreli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. International Journal of Gynaecology and Obstetrics 2000;70(2):209-62.
Bicher 1995
  • Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM. Ovarian malignant mixed mullerian tumors treated with platinum-based chemotherapy. Obstetrics and Gynecology 1995;85(5 Pt 1):735-9.
Brown 2004
Carlson 1983
Chang 1995
  • Chang J, Sharpe JC, A'Hern RP, Fisher C, Blake P, Shepherd J, et al. Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients. Annals of Oncology 1995;6(8):755-8.
Chun KC
  • Chun KC, Kim JJ, Kim DY, Kim JH, Kim YM, Nam JH, et al. Optimal debulking surgery followed by placlitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience. Gynecologic and Obstetric Investigation 2011;72(3):208-4.
Cicen 2008
  • Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, et al. Ovarian carcinosarcomas: clinicopathological prognositc factors and evaluation of chemotherapy regimens containing platinum. Gynecologic Oncology 2008;108(1):136-40.
Costa 1996
CTCAE 2006
  • National Cancer Institute : Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). (http://ctep.cancer.gov/forms/CTCAEv3.pdf) August 9th 2006.
Deeks 2001
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds) editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
DerSimonian 1986
Duska 2002
  • Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R, Fuller AF. Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary. Gynecologic Oncology 2002;85(3):459-63.
George 1991
  • George E, Marvivel JC, Dehner LP. Malignant mixed mullerian tumors: an immunohistochemical study of 47 cases with histogenic considerations and clinical correlation. Human Pathology 1991;22:215-23.
Guarino 1998
  • Guarino M, Giordano F, Palloti F, Polizzotti G, Tricomi P, et al. Malignant mixed mullerian tumor of the uterus, features favoring its origin from a common clone and epithelial-to-mesenchymal transformation mechanism of histogenesis. International Journal of Gynecological 2003;22:368-73.
Hanjani 1983
  • Hanjani P, Petersen RO, Lipton SE, Nolte SA. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature. Obstetrics and Gynecological Surveys 1983;38(9):537-45.
Harris 2003
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Jin 2003
  • Jin Z, Ogata S, Tamura G Katayama Y, Fukase M, Yajima M, et al. Carcinosarcomas (malignant mullerian mixed tumors of the uterus and ovary; a genetic study with special reference to histogenesis. International Journal of Gynecological Pathology 2003;22:368-73.
Jonson 2006
  • Jonson AL, Bliss RL, Truskinovsky A, Judson P, Argenta P, Carson L, et al. Clinical features and outcomes of uterine and ovarian carcinosarcoma. Gynecologic Oncology 2006;100:561-4.
Leiser 2007
  • Leiser AL, Chi DS, Ishill NM, Tew WP. Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience. Gynecologic Oncology 2007;105(3):657-61.
Morrow 1986
Muntz 1995
Parmar 1998
Prendiville 1994
Raji 2011
  • Raji R, Guzzo F, L, Varughese J, Cocco E, Bellone S, et al. Uterine and ovarian carcinosarcomas over expressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. Journal of Experimental & Clinical Cancer Research 2011;30(1):106.
Rauh-Hain 2011
  • Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM 2nd, Schorge JO. Carcinosarcoma of the ovary: a case-control study. Gynecologic Oncology 2011;121:477-81.
Russell 1992
  • Russell PB, Solomon HJ. Malignant mullerian and miscellaneous mesenchymal tumors of ovary ('ovarian sarcomas'). In: Coppleson M editor(s). Gynecologic Oncology. 2nd Edition. Churchill Livingstone, 1992:971-86.
Rutledge 2006
Sawada 2003
Schipf 2008
Signorelli 2009
  • Signorelli M, Chiappa V, Minig L, Fruscio R, Perego P, Caspani G, et al. Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma. International Journal of Gynecological Cancer 2009;19(6):1142-6.
Simon 1991
Sonoda 2000
Sutton 1994
  • Sutton GP, Blessing JA, Homesley HD, Malfetano JH. A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors tumours of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study. Gynecologic Oncology 1994;53:24-6.
Tate Thigpen 2004
  • Tate Thigpen J, Blessing JA, DeGeest K, Look KY, Homesley HD. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecologic Oncology 2004;93(2):336-9.
Terada 1989
The Cancer Genome Atlas Research Network 2011